Inflammation and IGF-I activate the Akt pathway in breast cancer - PubMed (original) (raw)
. 2007 Feb 15;120(4):796-805.
doi: 10.1002/ijc.22336.
Brenda J Boersma, Tiffany M Howe, Julie E Goodman, Douglas D Thomas, Lei Ying, Candice M Pfiester, Harris G Yfantis, John R Cottrell, Dong H Lee, Alan T Remaley, Lorne J Hofseth, David A Wink, Stefan Ambs
Affiliations
- PMID: 17096325
- DOI: 10.1002/ijc.22336
Inflammation and IGF-I activate the Akt pathway in breast cancer
Robyn L Prueitt et al. Int J Cancer. 2007.
Abstract
Akt signaling may promote breast cancer progression and poor disease outcome. We hypothesized that serum insulin-like growth factor I (IGF-I) and a proinflammatory tumor environment induce phosphorylation of Akt and downstream targets of Akt in breast cancer. We studied the relationship between Akt pathway activation, IGF-I and markers of inflammation, e.g., nitric oxide synthase-2 (NOS2), cyclooxygenase-2 (COX2) and tumor phagocyte density, in 248 breast tumors. We also examined the association of Akt phosphorylation with breast cancer survival. We observed that phosphorylation of Akt, BAD and caspase-9 correlated strongly with the expression of the 2 proinflammatory enzymes, NOS2 and COX2, in breast tumors (p < 0.001; Spearman rank correlation). Both NOS2 and COX2 expression were independently associated with Akt phosphorylation in the multivariate analysis. Serum IGF-I concentrations and the IGF-I/IGFBP3 ratio correlated with Akt phosphorylation at Thr308 and Ser473 in breast tumors (p <or= 0.05; Spearman rank correlation). The association with Akt phosphorylation at Thr308 remained statistically significant in the multivariate analysis. Akt pathway activation was not associated with overall survival in the unstratified analysis, but we observed a statistical interaction between Akt phosphorylation and tumor phagocyte density on breast cancer survival (p(interaction) < 0.05). We further corroborated our findings in cell culture models by demonstrating that ANA-1 macrophages, nitric oxide and prostaglandin E(2) induce Akt phosphorylation in human breast cancer cells. In summary, a proinflammatory environment was found to activate the Akt pathway in breast cancer, and may modify the association between the Akt phosphorylation status and breast cancer survival.
Similar articles
- NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.
Coutinho LL, Femino EL, Gonzalez AL, Moffat RL, Heinz WF, Cheng RYS, Lockett SJ, Rangel MC, Ridnour LA, Wink DA. Coutinho LL, et al. Int J Mol Sci. 2024 Jun 1;25(11):6103. doi: 10.3390/ijms25116103. Int J Mol Sci. 2024. PMID: 38892290 Free PMC article. Review. - Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Hermani A, et al. Cell Signal. 2013 Jun;25(6):1395-402. doi: 10.1016/j.cellsig.2013.02.018. Epub 2013 Mar 14. Cell Signal. 2013. PMID: 23499909 - Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Hossain DM, Banerjee S, Das K, Sa G, Das T. Lahiry L, et al. Carcinogenesis. 2010 Feb;31(2):259-68. doi: 10.1093/carcin/bgp240. Epub 2009 Dec 7. Carcinogenesis. 2010. PMID: 19969555 - Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G, Sailaja D. Chandrasekher G, et al. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3577-88. doi: 10.1167/iovs.04-0279. Invest Ophthalmol Vis Sci. 2004. PMID: 15452065 - Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
Ambs S, Glynn SA. Ambs S, et al. Cell Cycle. 2011 Feb 15;10(4):619-24. doi: 10.4161/cc.10.4.14864. Epub 2011 Feb 15. Cell Cycle. 2011. PMID: 21293193 Free PMC article. Review.
Cited by
- NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.
Coutinho LL, Femino EL, Gonzalez AL, Moffat RL, Heinz WF, Cheng RYS, Lockett SJ, Rangel MC, Ridnour LA, Wink DA. Coutinho LL, et al. Int J Mol Sci. 2024 Jun 1;25(11):6103. doi: 10.3390/ijms25116103. Int J Mol Sci. 2024. PMID: 38892290 Free PMC article. Review. - Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome.
Thomas D, Palczewski M, Kuschman H, Hoffman B, Yang H, Glynn S, Wilson D, Kool E, Montfort W, Chang J, Petenkaya A, Chronis C, Cundari T, Sappa S, Islam K, McVicar D, Fan Y, Chen Q, Meerzaman D, Sierk M. Thomas D, et al. Res Sq [Preprint]. 2024 Apr 3:rs.3.rs-4131804. doi: 10.21203/rs.3.rs-4131804/v1. Res Sq. 2024. PMID: 38645113 Free PMC article. Preprint. - Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency.
Panigrahi G, Candia J, Dorsey TH, Tang W, Ohara Y, Byun JS, Minas TZ, Zhang A, Ajao A, Cellini A, Yfantis HG, Flis AL, Mann D, Ioffe O, Wang XW, Liu H, Loffredo CA, Napoles AM, Ambs S. Panigrahi G, et al. JCI Insight. 2023 Dec 8;8(23):e170105. doi: 10.1172/jci.insight.170105. JCI Insight. 2023. PMID: 37906280 Free PMC article. - Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation.
Kuschman HP, Palczewski MB, Hoffman B, Menhart M, Wang X, Glynn S, Islam ABMMK, Benevolenskaya EV, Thomas DD. Kuschman HP, et al. Redox Biol. 2023 Nov;67:102928. doi: 10.1016/j.redox.2023.102928. Epub 2023 Oct 14. Redox Biol. 2023. PMID: 37866163 Free PMC article. - Nosip is a potential therapeutic target in hepatocellular carcinoma cells.
Gao J, Yang D, Huang Z, Pan X, Cao R, Lian C, Ma J, Li Y, Wang Z, Xia J. Gao J, et al. iScience. 2023 Jul 10;26(8):107353. doi: 10.1016/j.isci.2023.107353. eCollection 2023 Aug 18. iScience. 2023. PMID: 37529099 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous